Effect of LY2216684 on the Pharmacokinetics of Digoxin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2011
At a glance
- Drugs Digoxin; Edivoxetine
- Indications Atrial fibrillation; Atrial flutter; Attention-deficit hyperactivity disorder; Major depressive disorder
- Focus Pharmacokinetics
- 11 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2011 Planned End Date changed from 1 Jun 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 27 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.